tweetindex
TH

ASN Publications ✓

@asnpublications · Washington, DC · joined 27 Aug 2014

Showcasing the latest in kidney care, research, and innovation. Follow for updates from ASN publications, including JASN, CJASN, Kidney360, and Kidney News.

33 278Followers
1 750Following
5 277Posts total
8.1KViews on collected posts

โพสต์ล่าสุด

Incremental #PeritonealDialysis may reduce treatment burden and improve the patient experience, but practice varies widely and strong evidence is still lacking, according to article in #ASNCJASN. More research is needed to determine benefits and its impact on quality of life. htt 1.6K views · 15 likes · 5 reposts · 0 replies Open on X →
In primary membranous nephropathy, rituximab was associated with less kidney disease progression than calcineurin inhibitors, with similar remission and relapse outcomes, according to study in #ASNKidney360. https://t.co/fc2OR7KgV3 https://t.co/ldkCu5K0vb 2K views · 38 likes · 10 reposts · 0 replies Open on X →
A pilot from the Kidney Community Vaccination Collaborative across dialysis centers found major increases in shingles, RSV, and COVID-19 vaccination through on-site pharmacy partnerships: https://t.co/ja4imeaFhi @AsnEpc #ASNKidneyNews https://t.co/N8X5aB8I0M 1.1K views · 4 likes · 1 reposts · 0 replies Open on X →
By integrating implementation science, digital tools, patient advocacy, and health equity considerations, a consensus report published in #ASNCJASN, offers a practical roadmap for bringing evidence-based AKI care to every patient who needs it. https://t.co/dqEyeHQk7v https://t.co 1.2K views · 14 likes · 4 reposts · 0 replies Open on X →
New in #ASNJASN: The ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome addresses diagnosis and treatment of the CKM syndrome most relevant to the nephrology team and covers issues of special consideration for patients living with kidney diseases https://t 2.1K views · 25 likes · 12 reposts · 0 replies Open on X →

เทียบกับบัญชีขนาดเดียวกัน

5 โพสต์จาก 90 วันที่ผ่านมา เทียบกับช่วง 10K–100K ผู้ติดตาม แสดงต่อคนมากกว่าบัญชีขนาดเดียวกัน.

ยอดดูมัธยฐาน1 614บัญชีนี้924ค่ามัธยฐานของ 10K–100K
การเข้าถึง, %4.85%บัญชีนี้3.62%ค่ามัธยฐานของ 10K–100K
การมีส่วนร่วม, %1.49%บัญชีนี้1.52%ค่ามัธยฐานของ 10K–100K
ตัวชี้วัดบัญชีนี้ค่ามัธยฐานของ 10K–100Kอัตราส่วน
ยอดดูมัธยฐานต่อโพสต์1 6149241.75×
การเข้าถึง (ยอดดู ÷ ผู้ติดตาม)4.85%3.62%1.34×
อัตราการมีส่วนร่วม1.49%1.52%0.98×

บัญชีอื่นในช่วงนี้ →   เปรียบเทียบกับบัญชีอื่น →   ค่าอ้างอิงเหล่านี้คำนวณอย่างไร →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2.1K2 Sep
1.2K5 Sep
1.1K
2K
1.6K6 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.73%2 Sep
1.49%5 Sep
0.44%
2.46%
1.24%6 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes64.9%96 in total
Reposts21.6%32 in total
Bookmarks13.5%20 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

บัญชีที่คล้ายกัน